Correlation Between Oncopeptides and Xintela AB
Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Xintela AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Xintela AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncopeptides AB and Xintela AB, you can compare the effects of market volatilities on Oncopeptides and Xintela AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Xintela AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Xintela AB.
Diversification Opportunities for Oncopeptides and Xintela AB
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Oncopeptides and Xintela is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Xintela AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xintela AB and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Xintela AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xintela AB has no effect on the direction of Oncopeptides i.e., Oncopeptides and Xintela AB go up and down completely randomly.
Pair Corralation between Oncopeptides and Xintela AB
Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the Xintela AB. In addition to that, Oncopeptides is 1.25 times more volatile than Xintela AB. It trades about -0.16 of its total potential returns per unit of risk. Xintela AB is currently generating about -0.12 per unit of volatility. If you would invest 37.00 in Xintela AB on September 3, 2024 and sell it today you would lose (5.00) from holding Xintela AB or give up 13.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncopeptides AB vs. Xintela AB
Performance |
| Timeline |
| Oncopeptides AB |
| Xintela AB |
Oncopeptides and Xintela AB Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncopeptides and Xintela AB
The main advantage of trading using opposite Oncopeptides and Xintela AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Xintela AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xintela AB will offset losses from the drop in Xintela AB's long position.| Oncopeptides vs. BioInvent International AB | Oncopeptides vs. Alligator Bioscience AB | Oncopeptides vs. Swedish Orphan Biovitrum | Oncopeptides vs. Anoto Group AB |
| Xintela AB vs. Simris Alg AB | Xintela AB vs. Immunovia publ AB | Xintela AB vs. Sedana Medical AB | Xintela AB vs. KABE Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |